Use of Psoriasis Epidemiology Screening Tool (PEST) to Identify Psoriatic Arthritis in Bosnia and Herzegovina
Abstract
Background/Aim: Psoriatic arthritis (PsA) is chronic inflammatory disease with estimated prevalence of 6 % to 41 % in patients with psoriasis. The aim of this study was to determine the prevalence of PsA in Bosnian patients with psoriasis in everyday dermatological practice by using psoriasis epidemiology screening tool (PEST) screening test for detection of PsA.
Methods: This cross-sectional study included patients with a confirmed diagnosis of psoriasis. Data on patient demographics, clinical characteristics and treatment history, were collected using a questionnaire. Clinical characteristics of psoriasis included clinical cutaneous manifestations and plaques and psoriasis area and severity index (PASI). The risk of having PsA was evaluated by PEST (scores ≥ 3 indicate risk of PsA). The data were analysed using the Chi-square and Independent t-test.
Results: Of 79 included psoriatic patients, 22.8 % had a PEST ≥ 3. Psoriatic patients with PEST ≥ 3 were more likely to have certain comorbidities such as cardiovascular diseases (p = 0.044) and psychological disorders (p = 0.022). The psoriatic patients with PEST < 3 and PEST ≥ 3 did not differ in PASI severity, but psoriatic patients with PEST ≥ 3 were more likely to have nail psoriasis (p < 0.001).
Conclusion: In the present study, using PEST questionnaire, one fifth of Bosnian patients were suspected of having PsA, highlighting a need for improved screening for PsA in daily dermatological practice. Earlier care is important because these patients were more likely to have cardiovascular diseases, psychological disorders and nail disease.
References
Situm M, Bulat V. Psoriasis. Zagreb: Medixova medicinska biblioteka; 2022.
Ogdie A, Harrison RW, McLean RR, Lin TC, Lebwohl M, Strober BE, et al. Prospective cohort study of psoriatic arthritis risk in patients with psoriasis in a real-world psoriasis registry. J Am Acad Dermatol. 2022;87(6):1303-11. doi: 10.1016/j.jaad.2022.07.060.
Balaban J. Clinical dermatovenereology. Banja Luka: Pan-European University Apeiron; 2022.
American Academy of Dermatology [Internet]. Psoriatic arthritis: Diagnosis and treatment. [Cited: 11-Nov-2019]. Available from: (https://www.aad.org/diseases/psoriasis/psoriatic-arthritis-treatment).
Haroon M, Gallagher P, FitzGerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis. 2015;74(6):1045-50. doi: 10.1136/annrheumdis-2013-204858.
Helliwell SP. Psoriasis Epidemiology Screening Tool (PEST): A Report from the GRAPPA 2009 Annual Meeting. J Rheumatol. 2011;38(3)551-2. doi: 10.3899/jrheum.101119.
Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol. 2015;73(2):242-8. doi: 10.1016/j.jaad.2015.05.001.
Husni ME, Meyer KH, Cohen DS, Mody E, Qureshi AA. The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. J Am Acad Dermatol. 2007;57(4):581-7. doi: 10.1016/j.jaad.2007.04.001.
Gladman DD, Schentag CT, Tom BD, Chandran V, Brockbank J, Rosen C, et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS). Ann Rheum Dis. 2009;68(4):497-501. doi: 10.1136/ard.2008.089441.
Tinazzi I, Adami S, Zanolin EM, Caimmi C, Confente S, Girolomoni G, et al. The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology (Oxford). 2012;51(11):2058-63. doi: 10.1093/rheumatology/kes187.
Ibrahim GH, Buch MH, Lawson C, Waxman R, Helliwell PS. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin Exp Rheumatol. 2009;27(3):469-74. PMID: 19604440.
Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233-9. doi: 10.1002/art.24172.
Trettel A, Spehr C, Körber A, Augustin M. The impact of age on psoriasis health care in Germany. J Eur Acad Dermatol Venereol. 2017;31(5):870-5. doi: 10.1111/jdv.14115.
Ohata C, Anezaki H, Kaneko S, Okazaki F, Ito K, Matsuzaka Y, et al. Clinical characteristics of patients with psoriasis with family history: A multicenter observational study. J Dermatol. 2023;50(6):746-52. doi: 10.1111/1346-8138.16733.
Sbidian E, Chaimani A, Garcia-Doval I, Doney L, Dressler C, Hua C, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2022;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
Iskandar IYK, Parisi R, Griffiths CEM, Ashcroft DM, Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender. Br J Dermatol. 2021;184(2):243-58. doi: 10.1111/bjd.19169.
Shapiro J, Getz B, Cohen SB, Jenudi Y, Underberger D, Dreyfuss M, et al. Evaluation of a machine learning tool for the early identification of patients with undiagnosed psoriatic arthritis - A retrospective population-based study. J Transl Autoimmun. 2023;7:100207. doi: 10.1016/j.jtauto.2023.100207
Michalski P, Palazzo-Michalska V, Michalska-Bańkowska A, Bańkowski M, Grabarek BO. Impact of alcohol consumption, smoking, and diet on the severity of plaque psoriasis: a comprehensive assessment using clinical scales and quality of life measures. Med Sci Monit. 2023;29:e941255. doi: 10.12659/MSM.941255.
Urruticoechea-Arana A, Benavent D, León F, Almodovar R, Belinchón I, de la Cueva P, et al. Psoriatic arthritis screening: A systematic literature review and experts' recommendations. PLoS One. 2021;16(3):e0248571. doi: 10.1371/journal.pone.0248571.
Setoyama A, Sawada Y, Saito-Sasaki N, Ohmori S, Omoto D, Yamamoto K, et al. Psoriasis epidemiology screening tool (PEST) is useful for the detection of psoriatic arthritis in the Japanese population. Sci Rep. 2021;11(1):16146. doi: 10.1038/s41598-021-95620-4.
Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, et al. Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study. Rheumatology (Oxford). 2019;58(1):144-8. doi: 10.1093/rheumatology/key286.
Skornicki M, Prince P, Suruki R, Lee E, Louder A. Clinical burden of concomitant joint disease in psoriasis: a US-linked claims and electronic health records database analysis. Adv Ther. 2021;38(5):2458-71. doi: 10.1007/s12325-021-01698-7.
Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci. 2011;63(1):1-9. doi: 10.1016/j.jdermsci.2011.04.007.
Davidovici BB, Sattar N, Prinz J, Puig L, Emery P, Barker JN, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol. 2010;130(7):1785-96. doi: 10.1038/jid.2010.103.
Sajja AP, Joshi AA, Teague HL, Dey AK, Mehta NN. Potential immunological links between psoriasis and cardiovascular disease. Front Immunol. 2018;9:1234. doi: 10.3389/fimmu.2018.01234.
Juneblad K, Rantapaa-Dahlqvist S, Alenius GM. Disease activity and increased risk of cardiovascular death among patients with psoriatic arthritis. J Rheumatol. 2016;43(12):2155-61. doi: 10.3899/jrheum.160070.
Frede N, Hiestand S, Schauer F, Endres D, Tebartz van Elst L, Zeisbrich M, et al. Psoriasis and psoriatic arthritis have a major impact on quality of life and depressive symptoms: a cross-sectional study of 300 patients. Rheumatol Ther. 2023;10(6):1655-68. doi: 10.1007/s40744-023-00602-9.
Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ. Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol. 2020;39(1):217–25. doi: 10.1007/s10067-019-04734-8.
Kamalaraj N, El-Haddad C, Hay P, Pile K. Systematic review of depression and anxiety in psoriatic arthritis. Int J Rheum Dis. 2019;22(6):967–73. doi: 10.1111/1756-185X.13553.
Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31. doi: 10.1016/j.it.2005.11.006.
Husni ME, Merola JF, Davin S. The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum. 2017;47(3):351–60. doi: 10.1016/j.semarthrit.2017.05.010.
McEvoy AN, Bresnihan B, FitzGerald O, Murphy EP. Corticotropin-releasing hormone signalling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1α corticotropin-releasing hormone receptor. Arthritis Rheum. 2001;44(8):1761–7. doi: 10.1002/1529-0131(200108)44:8<1761::AID-ART311>3.0.CO;2-D.
Husted JA, Tom BD, Farewell VT, Gladman DD. Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2012;64(5):758-65. doi: 10.1002/acr.21602.
McHugh NJ. Verna Wright lecture: psoriatic arthritis: the need for early intervention. J Rheumatol Suppl. 2015;93:10-13. doi: 10.3899/jrheum.150625.
McGonagle D, Benjamin M, Tan AL. The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol. 2009;21(4):340-7. doi: 10.1097/BOR.0b013e32832c6ab9.
Rokutanda R, Kishimoto M, Okada M. Magnetic resonance angiography in psoriatic arthritis of the hand. J Rheumatol. 2012;39(8):1700. doi: 10.3899/jrheum.120483.
Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233-9. doi: 10.1002/art.24172.
Patrizi A, Venturi M, Scorzoni R, Pazzaglia M, Malavolta N, Bardazzi F. Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis? G Ital Dermatol Venereol. 2014;149(2):177-84. PMID: 24819637.
Michalski P, Palazzo-Michalska V, Michalska-Bańkowska A, Bańkowski M, Grabarek BO. Impact of alcohol consumption, smoking, and diet on the severity of plaque psoriasis: a comprehensive assessment using clinical scales and quality of life measures. Med Sci Monit. 2023;29:e941255. doi: 10.12659/MSM.941255.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).